Related Experiment Video

Updated: Jun 5, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Translating clinical trials into meaningful outcomes

Patricia M LoRusso1, Lowell E Schnipper, David J Stewart

  • 1Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA. lorussop@karmanos.org

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|December 21, 2010
PubMed

Insights

Developing new cancer therapies faces challenges due to healthcare system strain and limited clinical trials. Future progress requires innovative trial designs and patient-centered approaches for meaningful outcomes.

Area of Science:

  • Oncology
  • Translational Medicine
  • Health Services Research

Background:

  • The development of novel cancer therapies is hindered by a strained healthcare system and inadequate clinical trial infrastructure, often termed the "valley of death."
  • Traditional large phase III trials with modest incremental benefits are becoming less valuable for all stakeholders.
  • Translating scientific discoveries into clinically meaningful and cost-effective cancer treatments remains a significant challenge.

Purpose of the Study:

  • To propose a paradigm shift in clinical trial design and endpoint selection for identifying successful novel therapeutics.
  • To emphasize the need for scientific rigor in interpreting results and making informed decisions in cancer research.
  • To highlight the importance of patient engagement, healthcare access, and reform for the future of cancer clinical research.

Main Methods:

  • This study is a conceptual analysis and synthesis of current challenges and future directions in cancer drug development.
  • It reviews the limitations of existing clinical trial methodologies and proposes a shift towards more impactful outcomes.
  • The analysis emphasizes the need for a multidisciplinary approach involving various stakeholders.

Main Results:

  • A paradigm shift in clinical trial design and endpoints is necessary for identifying novel therapeutics with real-world impact.
  • Outcomes demonstrating robust magnitude and applicability are increasingly important.
  • Patient participation, improved healthcare access, and health reform are critical for the success of cancer research.

Conclusions:

  • The current model of cancer therapy development is at a critical juncture, necessitating innovative strategies.
  • Future success depends on redefining clinical trial paradigms, prioritizing patient-centric outcomes, and fostering broader stakeholder engagement.
  • Translating scientific breakthroughs into cost-effective, meaningful improvements in cancer care requires a fundamental reevaluation of the research enterprise.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...